See original article here PARIS and TORONTO, Jan. 4, 2018 /PRNewswire/ — Servier and Treventis announce strategic research partnership in targeting misfolded proteins implicated in neurodegenerative diseases. The collaboration covers a large drug discovery program targeting both tau and amyloïde-β (Aβ), two key proteins involved in Alzheimer’s disease. This therapeutic strategy aims to provide patients with a drug that slows…

2015 © Copyright - Bionova